Mayuresh M. Abhyankar

University of Virginia

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “IL-13 is a driver of COVID-19 severity”.

IL-13 is a driver of COVID-19 severity

medRxiv(2020)10.1101/2020.06.18.20134353

N/A

2.3DataRank · unranked

73 citations

Tara E. Sutherland, Chelsea Marie, Ben T. Bradley, Rebecca M. Carpenter, Jeffrey M. Sturek +23 more

IL-13 is a driver of COVID-19 severity

JCI Insight(2021)10.1172/jci.insight.150107

N/A

0.631DataRank · unranked

66 citations

Tara E. Sutherland, Chelsea Marie, Saskia Preissner, Benjamin T. Bradley, Rebecca M. Carpenter +23 more

Fecal microbiota transplantation promotes type 2 mucosal immune responses with colonic epithelium proliferation in patients with recurrent Clostridioides difficile

JCI Insight(2025)10.1172/jci.insight.195678

N/A

0.334DataRank · unranked

5 citations

Jiayi Tian, Nick R. Natale, Farha Naz, Mary K. Young, Uma Nayak +12 more

Binary toxin expression by Clostridioides difficile is associated with worse disease

medRxiv(2021)10.1101/2021.07.30.21261256

N/A

0DataRank · unranked

0 citations

Jhansi L. Leslie, Gregory R. Madden, David M. Lyerly, Robert J. Carman, David B. Stewart +3 more

Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac001

N/A

0DataRank · unranked

28 citations

Jhansi L. Leslie, Gregory R. Madden, David M. Lyerly, Robert J. Carman, Matthew W. Lyerly +4 more

Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M−052 liposomes): In vitro characterization

International Journal of Pharmaceutics(2022)10.1016/j.ijpharm.2022.122141

N/A

0DataRank · unranked

11 citations

John Z. Chen, Michael Rolo, Mohamed Eldam, Lynn Jordan, Sandra J. Sivananthan +10 more

Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection

Infection and Immunity(2023)10.1128/iai.00092-23

N/A

0DataRank · unranked

9 citations

Isaura Rigo, Rachel Boone, Mayuresh M. Abhyankar, Mary K. Young, William Basener +2 more

The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection

Anaerobe(2024)10.1016/j.anaerobe.2024.102842

N/A

0DataRank · unranked

9 citations

Mary K. Young, Mayuresh M. Abhyankar, Feifan Xu, Girija Ramakrishnan, Farha Naz +3 more

Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques

Human Vaccines & Immunotherapeutics(2024)10.1080/21645515.2024.2374147

N/A

0DataRank · unranked

4 citations

Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Y. Chen +14 more

Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant

npj Vaccines(2025)10.1038/s41541-025-01075-3

N/A

0DataRank · unranked

5 citations

Nicholas Hagspiel, Feifan Xu, Brandon Thompson, G. Brett Moreau, Mary Young +5 more

Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy

Frontiers in Immunology(2021)10.3389/fimmu.2021.683157

N/A

0DataRank · unranked

22 citations

Mark T. Orr, Robert Kinsey, Sandra J. Sivananthan, Andrew J. Nafziger, David N Oakland +18 more